Myelodysplastic syndrome: the other cause of anemia in end-stage renal disease patients undergoing dialysis

In end-stage renal disease (ESRD) patients receiving dialysis, anemia is common and related to a higher mortality rate. Erythropoietin (EPO) resistance and iron refractory anemia require red blood cell transfusions. Myelodysplastic syndrome (MDS) is a disease with hematopoietic dysplasia. There are...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Min-Yu, Lin, Sheng-Fung, Wu, Shih-Chi, Yang, Wen-Chi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7511931/
https://www.ncbi.nlm.nih.gov/pubmed/32968161
http://dx.doi.org/10.1038/s41598-020-72568-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7511931/
https://www.ncbi.nlm.nih.gov/pubmed/32968161
http://dx.doi.org/10.1038/s41598-020-72568-5

Ejemplares similares